Routine monitoring of essential fatty acids is not recommended in the NICE guidance. We have occasionally measured EFAs in patients where there was some concern about the possibility of deficiency, but have never found a problem. I think deficiency must be very rare, but would be interested in any evidence to the contrary. We certainly don't monitor routinely but I would like to know if others do so, and what the experience has been.
Best wishes
Ian
Prof.Ian S. Young
Professor of Medicine and Director of The Centre for Public Health
Queen's University Belfast
1st Floor ICS B Block
Royal Victoria Hospital
Grosvenor Road
Belfast
BT12 6BJ
Northern Ireland
tel: +44 (0) 2890 632743
fax: +44 (0) 2890 235900
email: [log in to unmask]
------ACB discussion List Information--------
This is an open discussion list for the academic and clinical community working in clinical biochemistry.
Please note, archived messages are public and can be viewed via the internet. Views expressed are those of the individual and they are responsible for all message content.
ACB Web Site
http://www.acb.org.uk
Green Laboratories Work
http://www.laboratorymedicine.nhs.uk
List Archives
http://www.jiscmail.ac.uk/lists/ACB-CLIN-CHEM-GEN.html
List Instructions (How to leave etc.)
http://www.jiscmail.ac.uk/
|